$EXPO
EXPONENT INC Stock $expo

$expo Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000114420418057083 Filed on November 02, 2018

Income Statement

Concept	2018 Q3	2017 Q3
Revenue	$95.30M	$87.56M
YoY Change	8.85%	12.81%
Cost Of Revenue	$6.600M	$5.200M
YoY Change	26.92%	30.0%
Gross Profit	$88.70M	$82.40M
YoY Change	7.65%	12.41%
Gross Profit Margin	93.07%	94.11%
Selling, General & Admin	$60.30M	$55.60M
YoY Change	8.45%	8.59%
% of Gross Profit	67.98%	67.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.600M	$1.600M
YoY Change	0.0%	6.67%
% of Gross Profit	1.8%	1.94%
Operating Expenses	$74.71M	$68.25M
YoY Change	9.46%	10.05%
Operating Profit	$20.59M	$19.31M
YoY Change	6.68%	23.79%
Interest Expense	$700.0K	$400.0K
YoY Change	75.0%	100.0%
% of Operating Profit	3.4%	2.07%
Other Income/Expense, Net	$3.395M	$2.725M
YoY Change	24.59%	17.2%
Pretax Income	$23.99M	$22.03M
YoY Change	8.89%	22.94%
Income Tax	$6.536M	$7.387M
% Of Pretax Income	27.25%	33.53%
Net Earnings	$17.45M	$14.64M
YoY Change	19.19%	29.71%
Net Earnings / Revenue	18.31%	16.72%
Basic Earnings Per Share	$0.33	$0.28
Diluted Earnings Per Share	$0.32	$0.27
COMMON SHARES
Basic Shares Outstanding	53.03M	52.74M
Diluted Shares Outstanding	54.30M	53.93M

Balance Sheet

Concept	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$202.4M	$165.6M
YoY Change	22.22%	2.16%
Cash & Equivalents	$121.0M	$89.81M
Short-Term Investments	$81.40M	$75.80M
Other Short-Term Assets	$11.20M	$10.70M
YoY Change	4.67%	-41.21%
Inventory
Prepaid Expenses
Receivables	$122.9M	$124.8M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$336.5M	$301.1M
YoY Change	11.76%	17.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$43.97M	$35.18M
YoY Change	24.98%	-6.08%
Goodwill	$8.607M	$8.607M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.415M	$1.515M
YoY Change	-6.6%	63.08%
Total Long-Term Assets	$144.4M	$134.6M
YoY Change	7.31%	5.03%
TOTAL ASSETS
Total Short-Term Assets	$336.5M	$301.1M
Total Long-Term Assets	$144.4M	$134.6M
Total Assets	$480.9M	$435.6M
YoY Change	10.39%	13.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.20M	$13.80M
YoY Change	-4.35%	58.62%
Accrued Expenses	$66.10M	$59.70M
YoY Change	10.72%	25.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$88.15M	$81.30M
YoY Change	8.42%	17.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.911M	$54.30M
YoY Change	-94.64%	2483.25%
Total Long-Term Liabilities	$2.911M	$54.30M
YoY Change	-94.64%	2483.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.15M	$81.30M
Total Long-Term Liabilities	$2.911M	$54.30M
Total Liabilities	$150.3M	$135.6M
YoY Change	10.81%	14.34%
SHAREHOLDERS EQUITY
Retained Earnings	$332.9M	$313.3M
YoY Change	6.27%	9.68%
Common Stock	$225.5M	$208.6M
YoY Change	8.1%	8.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$224.8M	$219.8M
YoY Change	2.29%	4.9%
Treasury Stock Shares	13.66M shares	7.043M shares
Shareholders Equity	$330.6M	$300.1M
YoY Change
Total Liabilities & Shareholders Equity	$480.9M	$435.6M
YoY Change	10.39%	13.03%

Cashflow Statement

Concept	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$17.45M	$14.64M
YoY Change	19.19%	29.71%
Depreciation, Depletion And Amortization	$1.600M	$1.600M
YoY Change	0.0%	6.67%
Cash From Operating Activities	$18.90M	$9.800M
YoY Change	92.86%	-30.99%
INVESTING ACTIVITIES
Capital Expenditures	-$3.300M	$828.0K
YoY Change	-498.55%	-91.45%
Acquisitions
YoY Change
Other Investing Activities	-$5.900M	-$4.000M
YoY Change	47.5%	-150.0%
Cash From Investing Activities	-$9.100M	-$4.900M
YoY Change	85.71%	-180.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.600M	-5.700M
YoY Change	15.79%	14.0%
NET CHANGE
Cash From Operating Activities	18.90M	9.800M
Cash From Investing Activities	-9.100M	-4.900M
Cash From Financing Activities	-6.600M	-5.700M
Net Change In Cash	3.200M	-800.0K
YoY Change	-500.0%	-105.23%
FREE CASH FLOW
Cash From Operating Activities	$18.90M	$9.800M
Capital Expenditures	-$3.300M	$828.0K
Free Cash Flow	$22.20M	$8.972M
YoY Change	147.44%	98.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	32966000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	30437000	USD
CY2018Q3	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	57432000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1415000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1346000	USD
CY2018Q3	us-gaap	Assets Assets	480893000	USD
CY2017Q4	us-gaap	Assets Assets	439589000	USD
CY2018Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13221000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14741000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2911000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3326000	USD
CY2018Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	57998000	USD
CY2017Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	52776000	USD
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8864000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8302000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	88145000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	93107000	USD
CY2017Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	48676000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120977000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	124794000	USD
CY2018Q3	us-gaap	Short Term Investments ShortTermInvestments	81373000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	71604000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	122911000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	110100000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11243000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9011000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	336504000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	315509000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43969000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35014000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	8607000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	8607000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	66060000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	70064000	USD
CY2018Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1205000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1292000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	150259000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	150501000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	66000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	66000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	225454000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	210230000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-288000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-236000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-2726000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-1793000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	332907000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	303990000	USD
CY2018Q3	us-gaap	Treasury Stock Value TreasuryStockValue	224779000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	223169000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	330634000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	289088000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	480893000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	439589000	USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.13
CY2018Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.13
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.39
CY2018Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6700000	USD
CY2018Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6764000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	20229000	USD
CY2017Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.105
CY2017Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.105
CY2017Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.105
CY2017Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.105
CY2017	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.420
CY2017Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5374000	USD
CY2017Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5424000	USD
CY2017Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5424000	USD
CY2017Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5416000	USD
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21638000	USD
CY2018Q3	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4163000	USD
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	5332000	USD
CY2018Q3	expo	Subcontractor Fees Not Included In Revenues SubcontractorFeesNotIncludedInRevenues	4700000	USD
	expo	Subcontractor Fees Not Included In Revenues SubcontractorFeesNotIncludedInRevenues	21900000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	605000	USD
CY2018Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	145248000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	9742000	USD
CY2018Q3	expo	Deferred Compensation Plan Liabilities Fair Value Disclosure DeferredCompensationPlanLiabilitiesFairValueDisclosure	65036000	USD
CY2018Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	65036000	USD
CY2017Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	134696000	USD
CY2017Q4	expo	Deferred Compensation Plan Liabilities Fair Value Disclosure DeferredCompensationPlanLiabilitiesFairValueDisclosure	59050000	USD
CY2017Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	59050000	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	202814000	USD
CY2018Q3	expo	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	0	USD
CY2018Q3	expo	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	464000	USD
CY2018Q3	expo	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	202350000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	196791000	USD
CY2017Q4	expo	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	0	USD
CY2017Q4	expo	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	393000	USD
CY2017Q4	expo	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	196398000	USD
CY2018Q3	expo	Available For Sale Securities Short Term Investments Amortized Cost Due In Year One AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne	39966000	USD
CY2018Q3	expo	Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo	41871000	USD
CY2018Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	81837000	USD
CY2018Q3	expo	Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne	39796000	USD
CY2018Q3	expo	Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo	41577000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53032000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52740000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52928000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52724000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54302000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53926000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54181000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53952000	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	35000000	USD
CY2016Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	35000000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	278364	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8431000	USD
CY2018Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	45376000	USD
	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	5892000	USD
	us-gaap	Treasury Stock Reissued At Lower Than Repurchase Price TreasuryStockReissuedAtLowerThanRepurchasePrice	5667000	USD
CY2018Q3	us-gaap	Trading Securities TradingSecurities	63270000	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	53350000	USD
CY2018Q3	expo	Deferred Compensation Plan Vested Amounts Due DeferredCompensationPlanVestedAmountsDue	65036000	USD
CY2017Q4	expo	Deferred Compensation Plan Vested Amounts Due DeferredCompensationPlanVestedAmountsDue	59050000	USD
CY2018Q3	expo	Change In Market Value Of Deferred Compensation Trust Assets ChangeInMarketValueOfDeferredCompensationTrustAssets	1840000	USD
CY2017Q3	expo	Change In Market Value Of Deferred Compensation Trust Assets ChangeInMarketValueOfDeferredCompensationTrustAssets	1699000	USD
	expo	Change In Market Value Of Deferred Compensation Trust Assets ChangeInMarketValueOfDeferredCompensationTrustAssets	2577000	USD
	expo	Change In Market Value Of Deferred Compensation Trust Assets ChangeInMarketValueOfDeferredCompensationTrustAssets	4617000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	19721000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	17208000	USD
	expo	Vested Restricted Stock Awards Issued To Settle Accrued Bonuses VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses	7643000	USD
	expo	Vested Restricted Stock Awards Issued To Settle Accrued Bonuses VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses	6910000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1643000	USD
CY2018Q3	expo	Revenue Before Reimbursements RevenueBeforeReimbursements	88714000	USD
CY2017Q3	expo	Revenue Before Reimbursements RevenueBeforeReimbursements	82359000	USD
	expo	Revenue Before Reimbursements RevenueBeforeReimbursements	269370000	USD
	expo	Revenue Before Reimbursements RevenueBeforeReimbursements	246946000	USD
CY2018Q3	expo	Revenue From Reimbursement RevenueFromReimbursement	6588000	USD
CY2017Q3	expo	Revenue From Reimbursement RevenueFromReimbursement	5196000	USD
	expo	Revenue From Reimbursement RevenueFromReimbursement	18010000	USD
	expo	Revenue From Reimbursement RevenueFromReimbursement	12571000	USD
CY2018Q3	us-gaap	Revenues Revenues	95302000	USD
CY2017Q3	us-gaap	Revenues Revenues	87555000	USD
	us-gaap	Revenues Revenues	287380000	USD
	us-gaap	Revenues Revenues	259517000	USD
CY2018Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	55639000	USD
CY2017Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	51493000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	168676000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	157447000	USD
CY2018Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7826000	USD
CY2017Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7500000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	22857000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	21966000	USD
CY2018Q3	expo	Cost Incurred From Reimbursable Expense CostIncurredFromReimbursableExpense	6588000	USD
CY2017Q3	expo	Cost Incurred From Reimbursable Expense CostIncurredFromReimbursableExpense	5196000	USD
	expo	Cost Incurred From Reimbursable Expense CostIncurredFromReimbursableExpense	18010000	USD
	expo	Cost Incurred From Reimbursable Expense CostIncurredFromReimbursableExpense	12571000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4655000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4061000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13167000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13277000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	74708000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	68250000	USD
	us-gaap	Operating Expenses OperatingExpenses	222710000	USD
	us-gaap	Operating Expenses OperatingExpenses	205261000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	20594000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	19305000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	64670000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	54256000	USD
CY2018Q3	us-gaap	Investment Income Net InvestmentIncomeNet	740000	USD
CY2017Q3	us-gaap	Investment Income Net InvestmentIncomeNet	372000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	1813000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	872000	USD
CY2018Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2655000	USD
CY2017Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2353000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4875000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6660000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3395000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2725000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6688000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7532000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23989000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22030000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	71358000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	61788000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6536000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7387000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15140000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16778000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	17453000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	14643000	USD
	us-gaap	Net Income Loss NetIncomeLoss	56218000	USD
	us-gaap	Net Income Loss NetIncomeLoss	45010000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.85
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
CY2018Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.130
CY2017Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.105
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.390
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.315
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	14643000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-304000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46826000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26964000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12170000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3354000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	456000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-933000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1046000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-31000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	13000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-52000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	17000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17118000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15112000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	55233000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	46073000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4710000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4762000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-87000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-314000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1359000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1657000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13605000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12728000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2510000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-421000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14170000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	39051000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8999000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1049000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3609000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3950000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-202000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2558000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	562000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	152000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	37788000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	20997000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	28000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	4000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21958000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20351000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8839000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9520000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8431000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1065000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1733000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	20497000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	16419000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28271000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32637000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-414000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	866000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	162000	USD
	expo	Capital Expenditures CapitalExpenditures	13665000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	51000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3817000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-25158000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	114967000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89809000	USD
	expo	Capital Expenditures CapitalExpenditures	3354000	USD
CY2018Q3	expo	Capital Expenditures CapitalExpenditures	4716000	USD
CY2017Q3	expo	Capital Expenditures CapitalExpenditures	828000	USD
CY2018Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1561000	USD
CY2017Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1567000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3912000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3526000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3014000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2029000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3912000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3526000	USD
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65707000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65707000	shares
CY2018Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	13655000	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	14169000	shares
CY2018Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.13
CY2018Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6765000	USD
	expo	Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm	P10Y
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "times new roman", times, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background: none; text-indent: 0.5in; white-space: pre-line; letter-spacing: 0px; top: 0px; font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;"><div style="font-weight:bold;display:inline;">           Use of Estimates. </div></div><div style="background: none; text-indent: 0.5in; letter-spacing: 0px; top: 0px; font-family: "times new roman", times, serif; font-size: 10pt;;display:inline;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-28
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Trading Symbol TradingSymbol	EXPO
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	EXPONENT INC
	dei	Entity Central Index Key EntityCentralIndexKey	0000851520
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure
CY2018Q3	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52012151	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure
CY2017Q3	expo	Entity Wide Sales Revenue Major Customer EntityWideSalesRevenueMajorCustomer	0.1	pure

Files In Submission

Name	View Source	Status
0001144204-18-057083-index-headers.html	Edgar Link	pending
0001144204-18-057083-index.html	Edgar Link	pending
0001144204-18-057083.txt	Edgar Link	pending
0001144204-18-057083-xbrl.zip	Edgar Link	pending
expo-20180928.xml	Edgar Link	completed
expo-20180928.xsd	Edgar Link	pending
expo-20180928_cal.xml	Edgar Link	unprocessable
expo-20180928_def.xml	Edgar Link	unprocessable
expo-20180928_lab.xml	Edgar Link	unprocessable
expo-20180928_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv505284_10q.htm	Edgar Link	pending
tv505284_ex31-1.htm	Edgar Link	pending
tv505284_ex31-2.htm	Edgar Link	pending
tv505284_ex32-1.htm	Edgar Link	pending
tv505284_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXPO
EXPONENT INC Stock $expo

2018 Q3 Form 10-Q Financial Statement

#000114420418057083 Filed on November 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXPO EXPONENT INC Stock $expo

2018 Q3 Form 10-Q Financial Statement

#000114420418057083 Filed on November 02, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXPO
EXPONENT INC Stock $expo